Namocatcat, Marites G.

HRN: 09-47-81  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2025
CEFTAZIDIME 1GM (VIAL)
01/28/2025
02/04/2025
IVT
1 Gm
Q8H
DM FOOT
Waiting Final Action 
01/28/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/28/2025
02/11/2025
IV
600mg
Q8hrs
DM FOOT
Waiting Final Action 
02/07/2025
CEFTRIAXONE 1G (VIAL)
02/07/2025
02/14/2025
IV
2G
OD X7days
S/p BKA, Right
Waiting Final Action 
02/12/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/12/2025
02/19/2025
IV
600mg
Q6
DM Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: